CDNA Competitors & Alternatives
Compare CareDx Inc with similar stocks in the same industry
Diagnostics & Research
CDNA
Main Stock$48.61
Tradestie Score
35
Market Cap
$798.40M
P/E Ratio
22.4
Revenue Growth
0.5%
Analyst Upside
+7.7%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$87.07
|
$3.26B | - | 39 | Compare |
|
VCYT
Veracyte, Inc.
|
$42.31
|
$2.85B | 29.9 | 65 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$79.54
|
$2.24B | - | 40 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.99
|
$2.22B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$145.59
|
$1.77B | - | 42 | Compare |
|
NEOG
Neogen Corp
|
$11.95
|
$1.26B | - | 42 | Compare |
|
OPK
Opko Health Inc.
|
$1.48
|
$1.23B | - | 39 | Compare |
|
NEO
NeoGenomics, Inc.
|
$16.98
|
$1.13B | - | 40 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$19.90
|
$719.31M | - | 53 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.20
|
$667.77M | - | 33 | Compare |
More CDNA Analysis
Data updated: Aug 22, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry